Inventor
HONG YUFENG
US25 patents
⚠️ This page may combine multiple inventors who share the name “HONG YUFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGOURON PHARMA
7 patentsUS6218426B1Apr 17, 2001
Non-peptide GnRH agents
AGOURON PHARMA29 citations91
US6469021B1Oct 22, 2002
Non-peptide antagonists of GLP-1 receptor and methods of use
AGOURON PHARMA23 citations89
US7101878B1Sep 5, 2006
Non-peptide GNRH agents, methods and intermediates for their preparation
AGOURON PHARMA41 citations87
US7381824B2Jun 3, 2008
Quinoline derivatives
AGOURON PHARMA7 citations73
US6849733B1Feb 1, 2005
Neuropeptide-Y ligands
AGOURON PHARMA4 citations60
US7923457B2Apr 12, 2011
Quinoline derivatives
AGOURON PHARMA0 citations52
US7928226B2Apr 19, 2011
Salts and polymorphs of a VEGF-R inhibitor
AGOURON PHARMA0 citations39
CONCORTIS BIOSYSTEMS CORP
5 patentsUS9801951B2Oct 31, 2017
Drug-conjugates, conjugation methods, and uses thereof
CONCORTIS BIOSYSTEMS CORP15 citations92
US9884127B2Feb 6, 2018
Drug-conjugates, conjugation methods, and uses thereof
CONCORTIS BIOSYSTEMS CORP13 citations90
US9981046B2May 29, 2018
Drug-conjugates, conjugation methods, and uses thereof
CONCORTIS BIOSYSTEMS CORP7 citations83
US12115228B2Oct 15, 2024
Drug-conjugates, conjugation methods, and uses thereof
CONCORTIS BIOSYSTEMS CORP0 citations60
US10967071B2Apr 6, 2021
Drug-conjugates, conjugation methods, and uses thereof
CONCORTIS BIOSYSTEMS CORP0 citations60
PFIZER
3 patentsUS7884117B2Feb 8, 2011
Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
PFIZER41 citations90
US6903132B2Jun 7, 2005
Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
PFIZER1 citations49
US6833372B2Dec 21, 2004
Non-peptide GnRH agents, Pharmaceutical compositions, and methods for their use
PFIZER1 citations43